Protect ICD
Project title: Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction.
SHIELD-Fabry
Low-dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease – prospective randomized controlled trial with cross-over (SHIELD-Fabry)
PICOLO-FH
ComParison of InClisiran Or aLirOcumab to standard therapy in pediatric Familial Hypercholesterolemia – the head-to-head PICOLO-FH clinical trial
COMBO-UC trial
Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis – the head to head COMBO-UC trial
cALL-POL
Childhood ALL in Poland (cALL-POL) project: a national harmonization of diagnostics and treatment of acute lymphoblastic leukemia in children
MAGIC-AML
MAGIC-AML – Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy – of Acute Myeloid Leukemia
LAMAinDiab
LAMAinDiab – lisdexamphetamine vs metylphenidate for pediatric patients with attention-deficit hyperactivity disorder and type 1 diabetes – randomized cross-over clinical trial
Alzheimer
Randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of dimethyl fumarate in brain atrophy reduction, synaptic functional connectivity, cognitive functions, quality of life, and activity of daily living improvement among patients with mild cognitive impairment and dementia due to Alzheimer’s disease.
STEADY
Prospective, randomized, open-label Phase III clinical trial with blinded endpoint assessing the efficacy and safety of ciclosporin and methotrexate in children and adolescents with moderate to severe atopic dermatitis.
Competition for non-commercial clinical trials – ABM/2025/1
On April 08, 2025, the Medical Research Agency (ABM) published the Competition Regulations for: „Open competition for non-commercial clinical trials– ABM/2025/1”. The main goal of the competition is the implementation of non-commercial clinical trials regarding the identification and evaluation of medicinal products. Among the most important tasks of the competition is to increase knowledge of the […]